QualityStocksNewsBreaks Archives - Page 377 of 1475

TuesdayJan 10, 2023 12:34 pm

QualityStocksNewsBreaks – CISO Global Inc. (NASDAQ: CISO) Inks Deal to Acquire South America-Based Cybersecurity Company

CISO Global (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider formally known as Cerberus Sentinel, has signed a definitive agreement to acquire RAN Security, a cybersecurity company headquartered in Buenos Aires, Argentina, and with offices in Chile, Peru, Bolivia, and Paraguay. According to the agreement, RAN Security will become a wholly owned subsidiary of Cerberus Sentinel. CISO Global anticipates the transaction will be finalized later this year following customary closing conditions and applicable regulatory approvals. RAN Security offers secured managed services to organizations across South America and is part of a growing network of companies acquired…

TuesdayJan 10, 2023 12:25 pm

QualityStocksNewsBreaks – Vision Energy Corp. (VENG) Incorporates Dutch Subsidiaries

Vision Energy (OTCQB: VENG), a forward-looking energy company developing carbon reduced solutions for the commercial, industrial and transportation sector, has incorporated new Dutch subsidiaries. These incorporations are designed to accommodate strategic initiatives for prospective partners, operators and launching customers for VENG’s integrated Green Energy Hub development in North Sea Port of Vlissingen, the Netherlands. According to the announcement, Vision Energy incorporated Vision Hydrogen BV as a project development company to develop, own and operate its planned Ammonia Cracking Facility. The facility will be used for back-cracking imported green ammonia to hydrogen gas as a service and will be combined with the…

TuesdayJan 10, 2023 12:06 pm

QualityStocksNewsBreaks – Data443 Risk Mitigation Inc. (ATDS) Secures VB100 Certification for Antivirus Product

Data443 (OTC: ATDS), a data security and privacy software company for “All Things Data Security,” today announced that its Data443(R) Antivirus Protection Manager(TM) has received VB100 certification. The certification is administered by Virus Bulletin, an independent organization that has tested antivirus products for more than 25 years. Joining leading organizations such as SentinelOne (NYSE: S), Fortinet (NASDAQ: FTNT), Avast Intego and Tacyon, Data443’s antivirus product is available for Microsoft Windows via desktops, laptops, virtual desktops, database engines, and Azure/AWS/GCP, along with hybrid cloud platforms and standard compute servers. “At Data443, we make every effort to help protect customers from the…

TuesdayJan 10, 2023 11:46 am

QualityStocksNewsBreaks – QSAM Biosciences Inc. (QSAM) Releases Shareholder Letter Outlining 2022 Updates, 2023 Milestone Goals

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases, has provided key updates and milestone goals in a shareholder letter; the letter is from QSAM Biosciences executive chair and cofounder C. Richard Piazza and CEO and cofounder Douglas Baum. The letter noted that QSAM is developing its lead therapeutic radiopharmaceutical drug candidate, CycloSam, to treat cancer that has either originated in the bone or has metastasized to the bone from the breast, prostate, lung or other organs. During 2022, CycloSam received rare pediatric disease designation for the…

TuesdayJan 10, 2023 11:34 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Key Milestones, 2023 Business Outlook

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today outlined key accomplishments from 2022 and provided a business update and catalysts for 2023. “Over the course of 2022, we strengthened our position as a leader in rare cannabinoid R&D, creating a unique offering as the only company that has the breadth and depth in cannabinoid drug research, development and significant manufacturing know-how,” said Eric A. Adams, InMed president and CEO. “Despite the many economic pressures affecting businesses on a global scale, including challenging capital markets, particularly in biotech, InMed…

TuesdayJan 10, 2023 11:13 am

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Signs $31M Definitive Agreement with Roynat Capital, Export Development Canada

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has entered a definitive agreement with existing lenders Roynat Capital (a subsidiary of the Bank of Nova Scotia) and Export Development Canada (EDC). According to the announcement, the agreement outlines the terms for a $31 million syndicated senior term loan, with Roynat and EDC each providing 50% of the proceeds. The company noted that funds will be used to support the upgrade and construction of EverGen’s RNG facilities, to provide $15 million for refinancing of existing debt and construction at Fraser Valley Biogas (“FVB”) and to provide $16…

TuesdayJan 10, 2023 10:52 am

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Begins Trading on Next-Gen Marketplace

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, announced that today at 10 a.m. EST, the company will start trading on Upstream under the ticker symbol JUPW. A revolutionary trading app for digital securities and NFTs, Upstream is powered by Horizon Fintex and MERJ Exchange Limited. The company noted that a digital collectible NFT commemorating the dual listing would be available for Upstream participants to claim using the code: JUPW. Through Upstream, investors around the world can invest in JUPW by downloading the Upstream app from their preferred app store and creating an account. Transactions…

MondayJan 09, 2023 2:12 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Kicks Off New Year with Multiple New Contracts, Announces Planned Path to Profitability

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, announced that it has secured four new contracts in a successful start of 2023. Under the contracts, Knightscope will deploy three K5 Autonomous Security Robots (“ASRs”) and five K1 Blue Light Towers. The deployment locations include an existing Knightscope channel partner’s regional corporate office in Jacksonville, Florida, an Illinois-based casino, as well as the parking lot of an apartment complex for a well-known learning institution. A teaching hospital has also purchased five K1 Blue Light Towers to improve communications and safety on its New…

MondayJan 09, 2023 1:10 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Leveraging Colombia, US Facilities to Distinguish Itself Within Highly Competitive Space

Flora Growth Corp. (NASDAQ: FLGC), a cannabis cultivator and global distributor, is a rapidly growing house of brands building customer bases and distribution channels across international lines as it aims to distinguish itself within a highly competitive arena. “Much of Flora Growth’s strength lies in its licensed cultivation, extraction and isolation facility located in northern Colombia’s fertile climate, where an experienced labor force is helping the nation emerge from decades of drug war illicit trade into a recognized and regulated market,” a recent article reads. “From its 247 acres of growing fields, the company’s harvests move into a production pipeline…

MondayJan 09, 2023 12:18 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Poised to Potentially Change History

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical innovator, is enrolling patients in the United States and Europe for its potentially pivotal global clinical trial in humans for its lead drug candidate designed to treat glioblastoma multiforme (“GBM”), a common and one of the most aggressive primary brain cancers. “The drug, Berubicin, is an anthracycline chemotherapy agent that apparently has the unique ability to cross the blood-brain barrier to target tumors directly. The inability of anthracyclines to cross the blood-brain barrier has been identified as a major obstacle in treating aggressive brain tumors such as GBM and creates an opportunity for CNS…

Site Search

Company Search

Category: QualityStocksNewsBreaks